# Celsense (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/celsense-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 3 |
| Citations | 2,145 |
| City | Pittsburgh |
| Country | US |
| Description | Celsense (United States) is a research organisation in Pittsburgh, US. OpenAlex records 33 works and 2,145 citations for it. |
| Homepage | https://celsense.com/ |
| OpenAlex ID | https://openalex.org/I4210114511 |
| Region | Pennsylvania |
| ROR ID | https://ror.org/01pghxv94 |
| Type | company |
| Works | 33 |

## University papers

- [Early access for innovative oncology medicines: a different story in each nation](https://scholariq.org/papers/early-access-for-innovative-oncology-medicines-a-different-story-in-each-nation/)
- [A Case Study of Teacher Leadership at an Elementary School](https://scholariq.org/papers/a-case-study-of-teacher-leadership-at-an-elementary-school/)
- [Financial Characteristics of Outcomes-Based Agreements: What Do Canadian Public Payers and Pharmaceutical Manufacturers Prefer?](https://scholariq.org/papers/financial-characteristics-of-outcomes-based-agreements-what-do-canadian-public/)
- [Building infrastructure for outcomes-based agreements in Canada: can administrative health data be used to support an outcomes-based agreement in oncology?](https://scholariq.org/papers/building-infrastructure-for-outcomes-based-agreements-in-canada-can/)
- [Data collection within patient support programs in Canada and implications for real-world evidence generation: the authors’ perspective](https://scholariq.org/papers/data-collection-within-patient-support-programs-in-canada-and-implications-for/)
- [Expanding the eligibility criteria for drugs in Canada’s time-limited health technology assessment and temporary drug access processes will further accelerate access to new medicines](https://scholariq.org/papers/expanding-the-eligibility-criteria-for-drugs-in-canada-s-time-limited-health/)
- [Practitioner Facilitated Peer Programs in Student Mental Health: Best Practice Case Examples](https://scholariq.org/papers/practitioner-facilitated-peer-programs-in-student-mental-health-best-practice/)
- [Accelerating Oncology Drug Reimbursement in Canada: Impact of the CDA-AMC Time-Limited Recommendation and pCPA Temporary Access Process](https://scholariq.org/papers/accelerating-oncology-drug-reimbursement-in-canada-impact-of-the-cda-amc-time/)
- [RWD164 ASCOT: A Case Study in Generating Timely and Meaningful Canadian Real-World Evidence To Support the Data Infrastructure Necessary for Innovative Patient Access](https://scholariq.org/papers/rwd164-ascot-a-case-study-in-generating-timely-and-meaningful-canadian-real/)
- [PT37 Operationalizing an Outcomes-Based MarketAccess Agreement Using Real-World Data From the Canadian Neuromuscular Disease Registry](https://scholariq.org/papers/pt37-operationalizing-an-outcomes-based-marketaccess-agreement-using-real-world/)

## University researchers

- [Allison Wills](https://scholariq.org/researchers/allison-wills/)

## University top topics

Showing 8 of 25.

- [Virus-based gene therapy research](https://scholariq.org/topics/virus-based-gene-therapy-research/)
- [Nanoplatforms for cancer theranostics](https://scholariq.org/topics/nanoplatforms-for-cancer-theranostics/)
- [Cancer Research and Treatments](https://scholariq.org/topics/cancer-research-and-treatments/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Lanthanide and Transition Metal Complexes](https://scholariq.org/topics/lanthanide-and-transition-metal-complexes/)
- [Nanoparticle-Based Drug Delivery](https://scholariq.org/topics/nanoparticle-based-drug-delivery/)
- [RNA Interference and Gene Delivery](https://scholariq.org/topics/rna-interference-and-gene-delivery/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.